GSK-2330672 Completed Phase 1 Trials for Type 2 Diabetes Mellitus Basic Science

IndicationsStatusPurposePhase
CompletedBasic Science1
clinicaltrials.gov IdentifierTitleDrugs
NCT01416324First Time in Human Study Using GSK2330672